<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="pro. 1. Introduction In December 2019, cluster of patients with" exact="pneumonia" post="were reported in Wuhan, Hubei Province, China. 1, 2"/>
 <result pre="; Mesecar, A. D. , Design and synthesis of peptidomimetic" exact="severe acute respiratory syndrome" post="chymotrypsin-like protease inhibitors. J Med Chem 2005, 48 ("/>
 <result pre="design and structural biology study of novel nonpeptide inhibitors of" exact="severe acute respiratory syndrome" post="coronavirus main protease. J Med Chem 2006, 49 ("/>
 <result pre="acetamides (ML188) as potent noncovalent small molecule inhibitors of the" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) 3CL protease. J Med Chem 2013, 56"/>
 <result pre="; Stauffer, S. R. , Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent"/>
 <result pre="D. , X-ray structure and inhibition of the feline infectious" exact="peritonitis" post="virus 3C-like protease: Structural implications for drug design. Bioorg"/>
</results>
